Epithelial cells activate fibroblasts to promote esophageal cancer development
- PMID: 36963399
- DOI: 10.1016/j.ccell.2023.03.001
Epithelial cells activate fibroblasts to promote esophageal cancer development
Abstract
Esophageal squamous-cell carcinoma (ESCC) develops through multistage epithelial cancer formation, i.e., from normal epithelium, low- and high-grade intraepithelial neoplasia to invasive carcinoma. However, how the precancerous lesions progress to carcinoma remains elusive. Here, we report a comprehensive single-cell RNA sequencing and spatial transcriptomic study of 79 multistage esophageal lesions from 29 patients with ESCC. We reveal a gradual and significant loss of ANXA1 expression in epithelial cells due to its transcription factor KLF4 suppression along the lesion progression. We demonstrate that ANXA1 is a ligand to formyl peptide receptor type 2 (FPR2) on fibroblasts that maintain fibroblast homeostasis. Loss of ANXA1 leads to uncontrolled transformation of normal fibroblasts into cancer-associated fibroblasts (CAFs), which can be enhanced by secreted TGF-β from malignant epithelial cells. Given the role of CAFs in cancer, our study underscores ANXA1/FPR2 signaling as an important crosstalk mechanism between epithelial cells and fibroblasts in promoting ESCC.
Keywords: ANXA1; FPR2; cancer-associated fibroblast; esophageal cancer; precancerous lesions.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment in
-
Insights into the co-evolution of epithelial cells and fibroblasts in the esophageal tumor microenvironment.Cancer Cell. 2023 May 8;41(5):826-828. doi: 10.1016/j.ccell.2023.03.020. Epub 2023 Apr 12. Cancer Cell. 2023. PMID: 37054715
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous